Categories
Uncategorized

Growing Aging Population Is Responsible For The Growth Of Osteopenia Treatment Market 2021-31

The Market Research Survey by Fact.MR, highlights the key reasons behind increasing demand and sales of Osteopenia Treatment . Osteopenia Treatment market drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review are addressed in the Osteopenia Treatment market survey report. The survey report provides a comprehensive analysis of Osteopenia Treatment market key trends and insights on Osteopenia Treatment market size and share.

Osteopenia Treatment Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Osteopenia Treatment insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Osteopenia Treatment market and quantified with insightful rationale.

To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=2579

Osteopenia Treatment Market: Segmentation

The global osteopenia treatment market can be segmented on the basis of test, method, end user and geography.

Based on test, the global Osteopenia Treatment market is segmented as:

  • Quantitative Computed Tomography (QCT)
  • Peripheral Quantitative Computed Tomography (pQCT)
  • Dual Energy X-ray Absorption (DEXA)
  • Peripheral Dual Energy X-ray Absorption (pDXA)
  • Others

Based on method, the global osteopenia treatment market is segmented as:

  • Invasive
  • Non-Invasive

Key questions answered in Osteopenia Treatment Market Survey Report:

  1. What is the current scenario and key trends in Osteopenia Treatment Market?
  2. What are the key strategies companies are adopting to increase their consumer base?
  3. What are the key categories within the Osteopenia Treatment segments and their future potential?
  4. What are the major Osteopenia Treatment Market drivers and their expected impact during the short, medium, and long terms?
  5. What is the Osteopenia Treatment Market size and what are the opportunities for the key players?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2579

Impact of Technology on Osteopenia Treatment Market

Introduction of advanced technologies such as artificial intelligence and 3D printing is revolutionizing the pharmaceutical industry. Adoption of these technologies have enabled the manufacturers to develop large volumes of drugs in a cost-effective manner.

Pharmaceutical manufacturers are looking for ways to leverage artificial intelligence and machine learning within healthcare and biotech industry. From drug discovery and drug manufacturing to optimizing medical treatment process, these technologies can play a critical role in the pharmaceutical industry.

Technological innovation not only impacts drug development but also the drug supply chain. New technology has enabled supply chain software to become faster and more efficient.

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current Osteopenia Treatment market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in Osteopenia Treatment market.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=2579

The Report Covers Exhaustive Analysis On:

  • Osteopenia Treatment Market Drivers, Segments and Restraints.
  • Osteopenia Treatment Market Survey and Dynamics
  • Osteopenia Treatment Market Size & Demand
  • Osteopenia Treatment Key Trends/Issues/Challenges
  • Osteopenia Treatment Sales, Competition & Companies involved

Explore Fact.MR’s Coverage on the Healthcare Domain:

Medical Coding Market– According to the latest research by Fact.MR, the medical coding market is set to witness significant growth during 2021-2031. Medical coding has always been in demand and is expected to remain at a steady growth in the forecasted period. Medical coding has been in demand in the U.S. as is designed to support Electronic Health Records (EHRs).

Ambulance Services Market According to the latest research by Fact.MR, the Ambulance Services market is set to witness steady growth during 2021-2031. The market is moderately fragmented and the demand for Ambulance Services will witness stable growth owing to the rising number of medical emergencies, a rapid rise in hospitals visits due to this pandemic as well as regular doctor visits.

mRNA Sequencing Market– According to the latest research by Fact.MR, the mRNA Sequencing market is set to witness steady growth during 2021-2031. The market has been a highly fragmented market developing at a gradual rate and is expected to witness lucrative growth with the increasing utilization of methodologies by major participants; the market is anticipated to increase over the projected skyline.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Osteoporosis Testing Sales Reliant on Surging Cases of Osteopenia: Fact.MR

Award winning market research company Fact.MR is conducting a study on the global osteoporosis testing market for the upcoming decade. As per its findings, the market is poised to witness credible gains across 2021, as the frequency of chronic bone diseases witness an escalating trend. Rising prevalence in different disorders such as rheumatoid arthritis, hyperparathyroidism, chronic kidney disease causing bone loss and osteopenia, providing an impetus to osteoporosis testing.

According to the study, lower cost of procedure and increased adoption in osteoporosis testing to provide a further boost to the demand. The U.S study of frequency of bone disease 2020 estimates, underpinned by the ageing population, the prevalence of osteoporosis and osteopenia was recorded to nearly 14 million cases of osteoporosis and over 47 million cases of low bone mass. Acknowledging the burden, the government incorporated various awareness campaign for osteoporosis testing, thus aiding the growth.

Furthermore, the study shows North America and Europe to emerge as the fastest growing and most lucrative market backed by the increasing number of patients visiting for osteoporosis testing. For instance, according to osteoporosis foundation by 2050, worldwide incidence of hip fracture in men is projected to rise by 310% and 240% in women. Hence, market players are investing in osteoporosis testing industry creating growth opportunities.

“Increasing number of chronic bone diseases and rising demand from the healthcare sector for advanced procedure, thereby widening the revenue prospects for key players operating within the market,” says the Fact.MR analyst.

Request Brochure at https://www.factmr.com/connectus/sample?flag=B&rep_id=1219

Key Takeaways

  • By product type, Dual energy x-ray absorptiometry (DEXA) expected to emerge as a lucrative segment, followed by FRAX tool
  • North America and Europe to collectively exhibit healthy growth
  • Asia Pacific to emerge as a potential market through 2021 and beyond
  • Breakthroughs in testing procedures expected to accelerate growth prospects across U.S.
  • Hospitals is anticipated to emerge as highly sought after end-user, attributed to the increased number of patients visiting for osteoporosis testing

Prominent Drivers

  • Fast reversal time and low cost procedure to boost the demand
  • Diverse application of osteoporosis testing procedures in tracking bone density to create growth prospects
  • Increasing cases of osteopenia is increasing bone tissue deterioration, bolstering osteoporosis testing prospects

Key Restraints

  • Lack of awareness between joint pains and osteoporosis and limitation to DEXA to hinder the growth
  • Potential side effects such as nosebleed, blood pressure fluctuations associated with the procedure to hamper the adoption rate

Request more information about Report Customization: https://www.factmr.com/connectus/sample?flag=RC&rep_id=1219

Competitive Landscape

GE Healthcare, Merck & Company, B.M.Tech Worldwide Co. Ltd., DMS Imaging, Swissray, Hologic Inc., Pfizer Inc., CompuMed Inc., and Eli Lilly & Company are some of the key players profiled by Fact.MR. According to the study, the market is fragmented in nature and key players are focusing on strategies like mergers and acquisition for future growth prospects.

For instance, in February 2021, Hologic acquired Biotheranostics, enabling entry into growing oncology market for approximately US$ 230 million.

In September 2020, U.S. FDA approved Pfizer’s XELJANZ® (TOFACITINIB) for the treatment of children with active polyarticular course juvenile idiopathic arthritis (pcJIA). However in January 2021, Pfizer shared the results to be negative and the criteria were not met for rheumatoid arthritis (RA).

More Insights on the Osteoporosis testing Market

In its latest report, Fact.MR offers unbiased analysis of the global osteoporosis testing market. The report divulges essential insights on osteoporosis testing market on the basis of product type (dexa-scan, FRAX tool, CT scans, X-rays, Ultrasounds), end-user (hospitals, orthopedics clinic, and ambulatory surgical centers), and regions (North America, Latin America, Europe, Japan, APEJ, and Middle East and Africa)

Explore Fact.MR’s Coverage on the Healthcare Domain

Preimplantation Genetic Testing Market: A recent study by Fact.MR on the Preimplantation Genetic Testing market offers an unbiased analysis on the opportunities and challenges for the forecast period. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Rift Valley Fever Testing Market: Fact.MR has published a new study to elucidate the potential growth parameters of the Rift Valley Fever Testing market. The study has been authored by a team of seasoned analysts who studied various geopolitical, macro and microeconomics, and sociological factors that can influence the growth of the market in order to reach valuable and reliable conclusions.

Nipah Virus Testing Market: Fact.MR’s expansive nipah virus testing market report sheds light on the prominent dynamics expected to shape future growth. The study explicates on the prominent drivers, opportunities and trends prevailing across key segments in prominent geographies. Also, information regarding prominent manufacturers has been embedded in the report.

About Us:

Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com